Cargando…

The Potential Role of Serotonergic Hallucinogens in Depression Treatment

Due to an increasing number of depression diagnoses and limited effective treatments, researchers continue to explore novel therapeutic strategies for this disorder. Recently, interest has revolved around the use of serotonergic psychedelics to reduce the symptoms of depression. In this systematic r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Psiuk, Dominika, Nowak, Emilia, Cholewa, Krystian, Łopuszańska, Urszula, Samardakiewicz, Marzena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8400004/ https://www.ncbi.nlm.nih.gov/pubmed/34440508 http://dx.doi.org/10.3390/life11080765

Ejemplares similares

Esketamine and Psilocybin—The Comparison of Two Mind-Altering Agents in Depression Treatment: Systematic Review
por: Psiuk, Dominika, et al.
Publicado: (2022)

Serotonergic hallucinogens/psychedelics could be promising treatments for depressive and anxiety disorders in end-stage cancer
por: dos Santos, Rafael Guimarães, et al.
Publicado: (2019)

Serotonergic hallucinogens and recognition of facial emotion expressions: a systematic review of the literature
por: Rocha, Juliana M., et al.
Publicado: (2019)

Serotonergic hallucinogens differentially modify gamma and high frequency oscillations in the rat nucleus accumbens
por: Goda, Sailaja A., et al.
Publicado: (2013)

MDMA-induced changes in within-network connectivity contradict the specificity of these alterations for the effects of serotonergic hallucinogens
por: Müller, Felix, et al.
Publicado: (2020)

Metabotropic Glutamate(2) Receptors Play a Key Role in Modulating Head Twitches Induced by a Serotonergic Hallucinogen in Mice
por: Benvenga, Mark J., et al.
Publicado: (2018)

Challenges in the Medical and Psychosocial Care of the Paediatric Refugee—A Systematic Review
por: Klas, Jakub, et al.
Publicado: (2022)

Is Shame Hallucinogenic?
por: McCarthy-Jones, Simon
Publicado: (2017)

How do serotonergic psychedelics treat depression: The potential role of neuroplasticity
por: Artin, Hewa, et al.
Publicado: (2021)

Associations between individual hallucinogens and hallucinogen misuse among U.S. Adults who recently initiated hallucinogen use
por: Jones, Grant, et al.
Publicado: (2023)

Poisonous & hallucinogenic mushrooms
por: Haard, Richard
Publicado: (1980)

Neurotoxicological profile of the hallucinogenic compound 25I-NBOMe
por: Herian, Monika, et al.
Publicado: (2022)

Psychopathological descriptive model of hallucinogenic/psychedelic drugs effect in the treatment of depression and addictions
por: Girala, N.
Publicado: (2022)

Hallucinogenic potential: a review of psychoplastogens for the treatment of opioid use disorder
por: Hornick, Mary G., et al.
Publicado: (2023)

A Non-Hallucinogenic Psychedelic Analog with Therapeutic Potential
por: Cameron, Lindsay P., et al.
Publicado: (2020)

Brain mechanisms of hallucinogens and entactogens
por: Vollenweider, Franz X.
Publicado: (2001)

Hallucinations and Hallucinogens: Psychopathology or Wisdom?
por: Bouso, José Carlos, et al.
Publicado: (2023)

A Review of Aeruginascin and Potential Entourage Effect in Hallucinogenic Mushrooms
por: Chue, P., et al.
Publicado: (2022)

The Effects of Four Compounds That Act on the Dopaminergic and Serotonergic Systems on Working Memory in Animal Studies; A Literature Review
por: Grosu, Ștefania-Alexandra, et al.
Publicado: (2023)

Hallucinogenic and poisonous mushroom field guide /
por: Menser, Gary P.
Publicado: (1977)

Psychedelic medicine and the clinical application of hallucinogens
por: eClinicalMedicine
Publicado: (2023)

Salvaging Salvinorin: From Hallucinogen to Potential Therapeutic through Chemical Synthesis
por: Duvvuru, Bhawyanth, et al.
Publicado: (2023)

Effect of Vitamin D Supplementation on Depression in Adults: A Systematic Review of Randomized Controlled Trials (RCTs)
por: Guzek, Dominika, et al.
Publicado: (2023)

β(2)-Adrenergic Receptor Activation Suppresses the Rat Phenethylamine Hallucinogen-Induced Head Twitch Response: Hallucinogen-Induced Excitatory Post-synaptic Potentials as a Potential Substrate
por: Marek, Gerard J., et al.
Publicado: (2018)

Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives
por: Martinotti, Giovanni, et al.
Publicado: (2018)

The Potential Role of Cannabinoids in Modulating Serotonergic Signaling by Their Influence on Tryptophan Metabolism
por: Jenny, Marcel, et al.
Publicado: (2010)

The role of the serotonergic system in suicidal behavior
por: Sadkowski, Marta, et al.
Publicado: (2013)

Modulation of Social Cognition via Hallucinogens and “Entactogens”
por: Preller, Katrin H., et al.
Publicado: (2019)

The Critical Exploration into Current Evidence behind the Role of the Nutritional Support in Adult Patients Who Undergo Haematogenic Stem Cell Transplantation
por: Pawłowski, Piotr, et al.
Publicado: (2023)

The Role of Ketamine in the Treatment of Bipolar Depression: A Scoping Review
por: Jawad, Muhammad Youshay, et al.
Publicado: (2023)

“Plants of the Gods” and their hallucinogenic powers in neuropharmacology — A review of two books
por: Faria, Miguel
Publicado: (2021)

Modulation of the Serotonergic Receptosome in the Treatment of Anxiety and Depression: A Narrative Review of the Experimental Evidence
por: Villas-Boas, Gustavo R., et al.
Publicado: (2021)

Salvia divinorum: from recreational hallucinogenic use to analgesic and anti-inflammatory action
por: Coffeen, Ulises, et al.
Publicado: (2019)

Editorial: Role of the serotonergic system in pathology of major depressive disorders
por: Norman, Trevor Ronald
Publicado: (2022)

Editorial: Role of serotonergic system in pathology of major depressive disorders
por: Fakhfouri, Gohar, et al.
Publicado: (2022)

Experimental Serotonergic Agents for the Treatment of Schizophrenia
por: Capuzzi, Enrico, et al.
Publicado: (2021)

Hallucinogens/psychedelics resurrected as new tools in psychiatric therapy
por: dos Santos, Rafael G., et al.
Publicado: (2020)

Classical Hallucinogens As Antidepressant Drugs: A Cautionary Approach
por: dos Santos, Rafael G., et al.
Publicado: (2023)

The Use of Classic Hallucinogens/Psychedelics in a Therapeutic Context: Healthcare Policy Opportunities and Challenges
por: dos Santos, Rafael Guimarães, et al.
Publicado: (2021)

BDNF Unveiled: Exploring Its Role in Major Depression Disorder Serotonergic Imbalance and Associated Stress Conditions
por: Correia, Ana Salomé, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r8blgsdfu0n736ab7cic798mt3